Condition: Leishmaniasis, Visceral · Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna
According to reports in the literature, from 2012 to date, there has been an increase in the number of diagnosed cases of autochthonous visceral Leishmania in the Province of Bologna. In this context, it was decided to carry out a retrospective prospective observational study, which is essential to describe the epidemiology of LV in order to outline the scientific and rational bases necessary for the drafting of guidelines to standardise the diagnostic and therapeutic approach to this disease, in order to reduce the diagnostic delay and improve therapeutic results. therapeutic outcome. In addition, epidemiological data will make it possible to identify possible new strategies to control the disease, which are essential for reducing its transmission.
This description comes directly from the study's public registry record.
Pierluigi Viale, MD · +390512143353 · pierluigi.viale@unibo.it
Silvia Cretella, BSc; MBio · +390512143353 · silvia.cretella@aosp.bo.it
Always discuss trial participation with your own doctor first.
| Ospedale M. Bufalini di Cesena, AUSL della Romagna | Cesena, Forlì-Cesena, Italy | Recruiting |
| Ospedale G.B. Morgagni L. Pierantoni di Forlì | Forlì, Forlì-Cesena, Italy | Recruiting |
| IRCCS Azienda Ospedaliero-Universitaria di Bologna | Bologna, Italy | Recruiting |
| Ospedale S. Maria delle Croci di Ravenna, AUSL della Romagna | Ravenna, Italy | Recruiting |
| Ospedale Infermi di Rimini, AUSL della Romagna | Rimini, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06793111